These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1993840)

  • 1. IL-1 induces ornithine decarboxylase in normal T lymphocytes.
    Bristol LA; Smith MR; Bhat NK; Durum SK
    J Immunol; 1991 Mar; 146(5):1509-15. PubMed ID: 1993840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitogens and lymphokines in the induction of ornithine decarboxylase (ODC) in T lymphocytes.
    Fidelus RK; Laughter AH; Twomey JJ
    J Immunol; 1984 Mar; 132(3):1462-5. PubMed ID: 6229581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
    Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
    J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP.
    Farrar WL; Vinocour M; Cleveland JL; Harel-Bellan A
    J Immunol; 1988 Aug; 141(3):967-71. PubMed ID: 2840461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of competence in resting B cells. The induction of cyclic AMP and ornithine decarboxylase activity after direct contact between B and T helper cells.
    Pollok KE; O'Brien V; Marshall L; Olson JW; Noelle RJ; Snow EC
    J Immunol; 1991 Mar; 146(5):1633-41. PubMed ID: 1847169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1beta induces ornithine decarboxylase activity in insulin-producing cells.
    Smismans A; Eizirik DL; Pipeleers DG
    Cytokine; 2000 Jan; 12(1):49-54. PubMed ID: 10623442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism.
    Bristol LA; Ruscetti FW; Brody DT; Durum SK
    J Immunol; 1990 Dec; 145(12):4108-14. PubMed ID: 2175324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
    Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
    Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC; Pober JS
    J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamines.
    Tiberio L; Maier JA; Schiaffonati L
    Cell Death Differ; 2001 Oct; 8(10):967-76. PubMed ID: 11598794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo.
    Scott DE; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1990 Oct; 145(7):2183-8. PubMed ID: 2144547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
    Endo Y; Kikuchi T; Nakamura M
    Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial lipopolysaccharide induction of ornithine decarboxylase in the macrophage-like cell line RAW264: requirement of an inducible soluble factor.
    Taffet SM; Haddox MK
    J Cell Physiol; 1985 Feb; 122(2):215-20. PubMed ID: 2578474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.